source
- Novartis commits $1.1B upfront to take Myricx Bio and its next-gen ADC platformNovartis said Monday it will be spending $1.1 billion upfront to buy Myricx Bio, which has an antibody-drug conjugate payload platform that could offer an edge over current approaches. The Swiss dr…Endpoints · 25d ago↗ source
- Convenience Kit Correction: Windstone Medical Packaging, Inc. Issues Correction for Convenience KitCertain Cardinal Health Webcol Large Alcohol Prep Pads in Custom Convenience Kits manufactured by Aligned Medical Solutions are not sterile.fda medwatch · 25d ago↗ source
- Anthropic launches Claude Science; House China panel probes trial sites; and moreHappy Fourth of July! We’ve got a handful of stories worth checking out before the backyard barbecue begins. But first: a reminder to submit your nominations for this year’s Women in Biopharma ...